Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-21.22%
↑ 94% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-329.25%
Historical baseline
PeriodValue
2025-21.22%
2024-649.11%
2023-646.67%
20220.00%